BioCentury
ARTICLE | Product R&D

JLABS seeks lung cancer solutions in Shanghai

Why JLABS Shanghai Head Sharon Chan sees lung cancer as a priority

November 8, 2018 10:41 PM UTC

As Johnson & Johnson gears up to launch its Shanghai JLABS site early next year, the incubator’s head, Sharon Chan, has pegged lung cancer as one of the first priorities.

Chan sees opportunity in China in multiple fields, as the country builds capabilities in artificial intelligence and big data. The prevalence of lung cancer means J&J can compete in an indication where it’s been late to the party in the U.S. ...

BCIQ Company Profiles

Johnson & Johnson